MechanismsHumansPreprint

Transitional senescent monocytes drive age-related inflammation in humans

Researchers identified a transient senescent-like monocyte state governed by the transcription factor AP-1 that primes cells toward inflammatory and sepsis-associated states.

A large monocyte beside four grey monocytes and four reddish senescent monocytes surrounded by inflammatory droplets.

bioRxiv

In aging humans, dysfunctional monocyte states contribute to systemic inflammation, but the underlying regulatory networks have remained unclear. In a new preprint, researchers used bulk and single-cell multidimensional integrative profiling to track monocyte state transitions during human aging. They found that a transient senescent-like population arising from classical CD14++CD16- monocytes drives the accumulation of an inflammatory monocyte state. This transition is orchestrated by the transcription factor AP-1, which acts on a pre-established chromatin landscape to rewire the cellular gene regulatory network. This process activates both senescence- and age-associated inflammatory transcriptional programs. Additionally, integrating these findings with clinical transcriptomic datasets revealed that aged and senescent-like monocytes are transcriptionally primed toward sepsis-associated states.

Why it matters

Identifying how transitional senescent states foster age-related inflammation reveals key regulatory mechanisms behind immune aging. It also points to AP-1 as a specific target for modulating systemic inflammation in older adults.

Caveats

This work is a preprint that has not yet undergone peer review. The conclusions are derived from observational profiling and transcriptomic dataset integration without reported interventional testing.

The paper

A transitional senescence program drives inflammatory monocyte state expansion in aging humans